These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 20402622)
1. Biomaterials, fibrosis, and the use of drug delivery systems in future antifibrotic strategies. Love RJ; Jones KS Crit Rev Biomed Eng; 2009; 37(3):259-81. PubMed ID: 20402622 [TBL] [Abstract][Full Text] [Related]
2. Foreign body reaction to biomaterials. Anderson JM; Rodriguez A; Chang DT Semin Immunol; 2008 Apr; 20(2):86-100. PubMed ID: 18162407 [TBL] [Abstract][Full Text] [Related]
3. Mast Cell-Biomaterial Interactions and Tissue Repair. Ozpinar EW; Frey AL; Cruse G; Freytes DO Tissue Eng Part B Rev; 2021 Dec; 27(6):590-603. PubMed ID: 33164714 [TBL] [Abstract][Full Text] [Related]
4. Host Responses to Biomaterials and Anti-Inflammatory Design-a Brief Review. Zhou G; Groth T Macromol Biosci; 2018 Aug; 18(8):e1800112. PubMed ID: 29920937 [TBL] [Abstract][Full Text] [Related]
5. T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response. Adusei KM; Ngo TB; Sadtler K Acta Biomater; 2021 Oct; 133():17-33. PubMed ID: 33905946 [TBL] [Abstract][Full Text] [Related]
8. Foreign body response to subcutaneous biomaterial implants in a mast cell-deficient Kit(w-Sh) murine model. Avula MN; Rao AN; McGill LD; Grainger DW; Solzbacher F Acta Biomater; 2014 May; 10(5):1856-63. PubMed ID: 24406200 [TBL] [Abstract][Full Text] [Related]
9. Macrophage and Fibroblast Interactions in Biomaterial-Mediated Fibrosis. Witherel CE; Abebayehu D; Barker TH; Spiller KL Adv Healthc Mater; 2019 Feb; 8(4):e1801451. PubMed ID: 30658015 [TBL] [Abstract][Full Text] [Related]
10. The pathology of the foreign body reaction against biomaterials. Klopfleisch R; Jung F J Biomed Mater Res A; 2017 Mar; 105(3):927-940. PubMed ID: 27813288 [TBL] [Abstract][Full Text] [Related]
12. Innate Immunity and Biomaterials at the Nexus: Friends or Foes. Christo SN; Diener KR; Bachhuka A; Vasilev K; Hayball JD Biomed Res Int; 2015; 2015():342304. PubMed ID: 26247017 [TBL] [Abstract][Full Text] [Related]
13. Macrophage reaction against biomaterials in the mouse model - Phenotypes, functions and markers. Klopfleisch R Acta Biomater; 2016 Oct; 43():3-13. PubMed ID: 27395828 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular biomaterials: when the inflammatory response helps to efficiently restore tissue functionality? Boccafoschi F; Mosca C; Cannas M J Tissue Eng Regen Med; 2014 Apr; 8(4):253-67. PubMed ID: 22730232 [TBL] [Abstract][Full Text] [Related]
15. Biomaterial-mesenchymal stem cell constructs for immunomodulation in composite tissue engineering. Hanson S; D'Souza RN; Hematti P Tissue Eng Part A; 2014 Aug; 20(15-16):2162-8. PubMed ID: 25140989 [TBL] [Abstract][Full Text] [Related]
16. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart. Tölli MA; Ferreira MP; Kinnunen SM; Rysä J; Mäkilä EM; Szabó Z; Serpi RE; Ohukainen PJ; Välimäki MJ; Correia AM; Salonen JJ; Hirvonen JT; Ruskoaho HJ; Santos HA Biomaterials; 2014 Sep; 35(29):8394-405. PubMed ID: 24985734 [TBL] [Abstract][Full Text] [Related]
19. The paracrine effects of adipose-derived stem cells on neovascularization and biocompatibility of a macroencapsulation device. Wang K; Yu LY; Jiang LY; Wang HB; Wang CY; Luo Y Acta Biomater; 2015 Mar; 15():65-76. PubMed ID: 25575852 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis with biomaterial-based drug- and cell-delivery systems. Patel ZS; Mikos AG J Biomater Sci Polym Ed; 2004; 15(6):701-26. PubMed ID: 15255521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]